International Journal of Medicine and Data

Objective: To analyze the clinical treatment methods and effects of 32 cases of chronic obstructive pulmonary disease (COPD). Methods: A total of 32 patients with chronic obstructive pulmonary disease in our hospital from January 2021 to January 2022 were selected. The number table was randomly divided into two groups: 16 patients in each group. The patients in the control group were treated with terbutaline, and the patients in the observation group were added with fluticasone propionate and glutathione on this basis. Compare the forced expiratory volume, vital capacity, peak expiratory flow rate, peripheral cellular immune function and inflammatory index tumor necrosis factor before and after treatment- α, Interleukin-6 and high-sensitivity C-reactive protein, total effective rate and adverse reaction. Results: The forced expiratory volume, vital capacity, peak expiratory flow rate and peripheral cellular immune function of patients in the observation group were higher than those in the control group after treatment, and the inflammatory index, tumor necrosis factor-α, Interleukin-6 and high-sensitivity C-reactive protein were lower than those in the control group, and the total effective rate was higher than that in the control group (P<0.05). There was no significant difference in adverse reactions between the two groups (P>0.05). Conclusion: Terbutaline combined with glucocorticoid and glutathione is effective in the treatment of chronic obstructive pulmonary disease.

terbutaline; Glucocorticoid; Glutathione; Chronic obstructive pulmonary disease; Application effect